Silence Therapeutics Announces Pricing Of Upsized $175 Million Underwritten Public Offering
SLN•Offering priced at $13.50 per ADS
Aug. 11 (Reuters) - Silence Therapeutics PLC said:
- Silence Therapeutics announces pricing of upsized $175 million underwritten public offering.
- Silence Therapeutics prices public offering of 12,962,963 ADSs at $13.50 per ADS.
Source text: ID:nBw7xKQ1fa
Further company coverage: SLNCF.PK
